UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $617 | -47.0% | 53,877 | -6.9% | 0.01% | -55.6% |
Q1 2023 | $1,165 | +34.1% | 57,867 | +50.9% | 0.03% | +8.0% |
Q4 2022 | $869 | -99.6% | 38,350 | +755.1% | 0.02% | +316.7% |
Q2 2020 | $202,000 | -1.9% | 4,485 | +3.5% | 0.01% | -25.0% |
Q1 2020 | $206,000 | -60.2% | 4,332 | -92.0% | 0.01% | -57.9% |
Q3 2017 | $518,000 | +55.1% | 54,000 | 0.0% | 0.02% | +35.7% |
Q2 2017 | $334,000 | +5.0% | 54,000 | -1.8% | 0.01% | +7.7% |
Q1 2017 | $318,000 | +278.6% | 55,000 | +266.7% | 0.01% | +225.0% |
Q4 2016 | $84,000 | -29.4% | 15,000 | +50.0% | 0.00% | -20.0% |
Q1 2016 | $119,000 | -64.0% | 10,000 | -50.0% | 0.01% | -78.3% |
Q4 2015 | $331,000 | +35.1% | 20,000 | +66.7% | 0.02% | +109.1% |
Q3 2015 | $245,000 | +21.9% | 12,000 | -6.8% | 0.01% | +175.0% |
Q1 2014 | $201,000 | – | 12,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |